This is a $1,999,994.00 Small Business Innovation Research (SBIR) Phase III contract awarded by the National Aeronautics and Space Administration (NASA) to The DNA Medicine Institute, Inc. for the development of the RHealth X, a universal biomedical analyzer device. The goal is to create a single palm-sized device capable of diverse biomedical analysis tasks such as cell cytometry, vitals monitoring, and multiplex nanostrip tests. This contract supports the further development and FDA 510(k)...
The Department of the Army Medical Command awarded a $999,812.85 firm fixed price definitive contract to Advanced Life Technologies, LLC of Santa Barbara, California under Topic DHA17-002 of the Department of Defense Small Business Innovation Research Program Phase II solicitation. The contract calls for Advanced Life Technologies to perform research and development of additive manufacturing techniques for biomimetic self-healing composite tissues through May 2022. As a total small business...
This is a delivery order issued under a $35 million Indefinite Delivery Contract (IDC) between Actuated Medical, Inc. (a woman-owned small business based in Bellefonte, Pennsylvania) and the National Institute on Drug Abuse (NIDA). The contract supports the Blueprint MedTech (BPMT) Initiative, which aims to develop innovative medical technologies for nervous system disorders. This specific delivery order, valued at $81,702, is for research and development services related to biocompatibility...
This is a $3,739,154.46 firm fixed-price contract awarded by the Office of Naval Research (ONR) to Becton, Dickinson & Co (BD) for the development of a next-generation immuno-analysis platform for use in Role 1 military medical settings. The contract has an ultimate completion date of January 25, 2018 and was not set aside for small businesses. BD is a leading manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical...
Advanced Life Technologies, LLC, doing business as Advanced Life Technologies LLC, has been awarded a $1.55 million firm fixed price contract by the Department of the Army Medical Command to continue research and development efforts initiated under the Small Business Innovation Research Program Phase II Enhancement. The contract will support Advanced Life Technologies' work to integrate direct write sensors with surgical training models for the Army's medical research programs. As a total...
Biosensics LLC has been awarded a $325,000 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct research and development activities aligned with the agency's goals. Specifically, the contract calls for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, as outlined in NIH and CDC Solicitation A Solicitation of the National Institutes of...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Research And Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation, for the procurement of recombinant human TGF-beta. The $23,906.25 firm fixed-price purchase order has a completion date of September 30, 2013. R&D Systems is a manufacturer and supplier of research reagents, antibodies, ELISA kits, and other biomedical products to various federal agencies, including the...
The Department of the Army Medical Command awarded a definitive contract valued at $1,030,550.66 to Cambridge Research & Development, Inc. of Nashua, New Hampshire under the Small Business Innovation Research Program Phase II. The two-year firm fixed price contract calls for medical research and development services to advance a patient transportable tactical combat casualty care documentation capability, as described in the project titled "Patient Transportable Tactical Combat Casualty...
This is a Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract, valued at $3,414,353.36, is for R&D in the area of biomedical applied research and exploratory development. Two subcontractors, Ambiopharm, Inc. and Shanghai Chempartner Co., LTD., have been engaged to provide custom peptides and bio compounds in...
This is a delivery order under the Medical Product Research and Development multiple-award contract, awarded by the U.S. Army Medical Command (MEDCOM) to PPD Development LP, a global contract research organization. The $495,898.15 cost-plus-fixed-fee contract is for market research, with the option for analysis of alternatives, related to hemorrhage detection. The award did not use a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher Scientific and has extensive...